R21/Matrix-M vaccine: optimising supply, maximising impact

Chukwudi A Nnaji1, Uchenna A Amaechi2, Charles S Wiysonge3

  • 1Division of Epidemiology and Biostatistics, School of Public Health and Family Medicine, University of Cape Town, Cape Town 7925, South Africa; Cochrane South Africa, South African Medical Research Council, Cape Town, South Africa; Technical Department, Malaria Consortium, London, UK.

Lancet (London, England)
|February 10, 2024
PubMed
Summary

No abstract available in PubMed .